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BMIThe evidence linking body mass index (BMI) to severe OA shows a strong association in the knee. There are
limited data exploring the effect of BMI on the risk of joint arthroplasty in a healthy population with long
periods of follow up. We compared the self-reported BMI at age 20, measured BMI at baseline, year 5 and year
10 with the year 19 risk of total knee arthroplasty (TKA) in a well-described, population based cohort of
healthy women. A total of 733 women attended the 19th year visit, of whom 31 underwent TKA and 676 were
used as a control group after 26 were removed for having hip arthoplasty.
Using logistic regression, an increase in 1 unit of BMI at baseline was associated with a 10.5% increased risk of
TKA (p=0.017) and at year 5 the increased risk is 8.6% (p=0.042). When adjusted for baseline age and
smoking, baseline BMI was the only signiﬁcant predictor of TKA at 10.0% with p=0.024. There was no
signiﬁcant association at 10 years or for change in BMI over time.
In this prospective, population based study, BMI predicted the risk of TKA for OA. The riskwas greatest at baseline
when the patients were inmiddle age suggesting that this is themost important time to target weight reduction
interventions.rthopaedics, Rheumatology &
, Windmill Rd., University of
-NC-ND license.© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Osteoarthritis (OA) of the major joints in the lower limb is a
painful and disabling condition that accounts for an enormous
healthcare burden [1–3]. The pathogenesis of OA is complex and
thus predicting individuals in a healthy population who will progress
to develop severe OA remains difﬁcult. Consequently, there is a
paramount need to reliably identify high-risk population cohorts who
can be targeted for future therapeutic trials, for early intervention of
modiﬁable risk factors and for ongoing research into the complex
disease process and natural history of progression of OA.
There aremany risk factors associatedwith end-stage knee OA [4,5],
however few are as modiﬁable as body mass index (BMI) [6]. There is
currently a strong level of evidence correlating BMI to future
radiographic OA and clinical OA of the knee [7–9] with a similar but
weaker association with the hip [10,11]. Whilst the link between BMI
and end-stage OA in the knee continues to be scrutinised, it is also of
interest to know how temporal changes in weight affect OA risk. Of the
previous studies that have investigated this relationship, few have
looked at change in BMI and end stage disease in a healthy community-based sample followed for almost 20 years. Additionally, surgically
relevantOAendpoints suchas total joint arthroplasty (TJA) have seldom
been used, with many studies favouring radiographic change and
clinical score severity as surrogate endpoints for OA [12–14].
The present study investigated the relationship between BMI
measurements at different time points and risk of end-stage OA in the
knee, deﬁned by TKA.
2. Patients and methods
In 1989, all women between 45 and 64 years of age who were
registered at the samemedical practice in Chingford, North-East London
were invited to join in this longitudinal prospective study. The primary
focus of the study was to investigate the natural history of osteoporosis
and osteoarthritis. A total of 1003 women volunteered to join the study
at its commencement, representing 78% of the initially invited women.
At year 19, 733 of these women were still actively involved in yearly
follow-up clinics (104 had died, 78 dropped out, 62moved away, 23 did
not respond and threewere too ill to attend). The clinical characteristics
of the cohort and selected group are shown in Table 1. At study baseline
(year 1), each individualwasmeasured for height andweight. Also, each
participant was asked to estimate their body weight from when they
were aged 20. Thesemeasurements were taken in addition to extensive
medical history questionnaires, social history, SF36 forms and radio-
logical and serological investigations. Follow-up clinics were conducted
Table 1
Clinical characteristics.
Characteristic Case control respondents
at year 19 (n=707)
Control group respondents
at year 19 without TJA (n=676)
Case group respondents
at year 19 with TKA (n=31)
Baseline age, years, median (IQR) 53 (48,58) 53 (48,58) 53 (51,59)
Baseline weight, kg, median (IQR) 64.8 (58.5,72.3) 64.4 (58.3,72) 68.6 (64,74.8)*
Height, m, mean (SD) 1.62 (0.06) 1.62 (0.06) 1.62 (0.06)
BMI at age 20, kg/m2, median (IQR) 20.9 (19.3,22.8) n=705 21.4 (19.8,23.5) n=674 21.6 (19.5,23.5)
BMI at Year 1 (baseline), kg/m2, median (IQR) 24.7 (22.6,27.3) 24.5 (22.6,27.2) 26.5 (24.1,28.8)*
BMI at year 5, kg/m2, median (IQR) 25.6 (23.1,28.5) n=650 25.5 (23.0,28.3) n=621 27.4 (25.1,29.4)* n=29
BMI at year 10, kg/m2, median (IQR) 26.3 (23.6,29.3) n=679 26.1 (23.5,29.3) n=651 27.5 (24.9,31.3) n=28
Baseline activity score, range=[3,12], median (IQR) 7 (6,8) n=702 7 (6,8) n=670 7 (6,8)
Baseline parity, range=[0,9], median(IQR) 2 (1,3) 2 (1,3) 2 (1,3)
Age of menopause, years, median (IQR) 49 (45,51) n=519 49 (45,51) n=491 47.5 (42,51) n=28
Smoking,% never, ever 56.6,43.4 56.8,43.2 51.6,48.4
*p-values b0.05, for cases verses controls.
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were sent thereafter.
During the follow up period, TKA was deemed to be due to OA
where OA was listed as the primary indication. Only cases where OA
was listed as indication for TKA were included in the study, whereas
cases with other indications for TKA (rheumatoid arthritis, trauma,
etc.) were excluded. Of the respondents remaining in the study at year
19, 31 had received a TKA due to OA and one had received TKA due to
RA. Individuals who underwentmore than one TKA during the follow-
up period were only counted once. Arthroplasty records were initially
gathered via patient testimony at annual follow-up clinics and then
validated by veriﬁcation with each individual's General Practitioner
records. Indications for arthroplasty were also veriﬁed during this
validation process. The TKA cases were compared against a control
group comprising those respondents remaining in the study at year 19
who did not have TJA (TKAs and/or THAs were excluded to create a
more stringent control group, n=676).
BMI (deﬁned as weight/height2) was calculated at four time points
(recalled BMI at age 20, measured BMI at baseline, year 5 and year 10).
Individual BMI measurements were stratiﬁed into categories based on
the World Health Organization (WHO) classiﬁcation: underweight
(BMI b18.50), normal (BMI 18.50–24.99), overweight (BMI 25–29.99)
and obese (BMI≥30.00) at each time point. The changes in BMI
between different time points t1 and t2 (deﬁned as ΔBMIt1,t2=BMI at
t2−BMI at t1, where t2N t1) were also calculated. Approval for this
study was granted by the Redbridge and Waltham Forest ethics
committee and all patients were consenting volunteers who freely
donated their time.Fig. 1. Four time points stratiﬁed by the WHO categories for BMI, showing the
percentage of patients within each group that had TKA by year 19 (based on case
control respondents).3. Statistical analyses
The baseline clinical characteristics of the respondents at year 19
(case and control groups) were compared against the non-respon-
dents using the Mann–Whitney test, two tailed unpaired t-test with
unequal variances and the Fisher's exact test for non-normal, normal
and categorical data respectively (results discussed but not shown).
The same was done when comparing TKA cases against the control
group (shown in Table 1).
The correlation of BMI at different time points was assessed using
the Spearman correlation matrix. This produced high values (N80%)
between pairs of measured BMI at baseline, year 5, year 10, suggesting
that an overall model incorporating multiple time points would be
unsuitable. Therefore the value of BMI as a predictor at each individual
time point rather than collectively was reviewed.
Logistic regression, adjusted for age at baseline and smoking
(“never” or “ever”) was performed using TKA by year 19 as the
outcome and BMI (for each time point or ΔBMIt1,t2) as the exposure.
Using 90% power at the 5% signiﬁcance level, the detectable departure
from the mean of baseline BMI was 0.65kg/m2.Stata SE v10, StatCorp, College Station, TX, USA andMatlab R2010a,
The Mathworks, Natick, MA, USA was used for the analyses.4. Results
The baseline clinical characteristics of case control respondents used in this study
(n=707) were compared to the non-respondents (n=296). The respondents were
younger than than the non-respondents on entry to the study (median age 53 versus
57 years, pb0.0005), had a lower BMI (median BMI 24.7 versus 25.3 kg/m2, p=0.026)
and had less smokers in their group (43.4% versus 52.7%, p=0.004). When compared
against the controls, the women who underwent TKA (cases group) during the follow-
up period had signiﬁcantly elevated BMI measurements at baseline (median 26.5
versus 24.5 kg/m2, p=0.005) and year 5 (median 27.4 versus 25.5 kg/m2, p=0.022) as
shown in Table 1. They did not however have an increased self reported BMI at age 20
compared to controls (median 21.6 versus 21.4 kg/m2, p=0.251). There were no other
signiﬁcant associations.
Individual BMI measurements were grouped into the WHO classiﬁcations. The risk
(percentage of patients) of TKA was calculated for each WHO category at age 20, study
baseline, year 5 and 10 (Fig. 1). There was no obvious relationship identiﬁed between
estimated BMI at age 20 and TKA. Therewas an increase in risk of TKAwith increased BMI
at baseline, but this was attenuated at years 5 and 10.
Logistic regression analyses using TKA as the outcome and BMI as the univariate
exposure (BMI at age 20, baseline, year 5, year 10 and BMI changes ΔBMIa20,y1, ΔBMIy1,
y5, ΔBMIy5,y10, ΔBMIy1,y10) revealed that the signiﬁcant predictors of TKA were BMI at
baseline with an OR(95% CI) of 1.105 (1.018, 1.198), p=0.017 and BMI at year 5, 1.086
(1.003, 1.175), p=0.042. When adjusted for baseline age and smoking, the BMI at
baseline was the only signiﬁcant predictor 1.100 (1.013, 1.195), p=0.024. The
association with BMI at year 5 was of borderline statistical signiﬁcance 1.082 (0.998,
1.173), p=0.056. No other signiﬁcant values were found for predicting TKA, although
all OR's were greater than 1, as shown in Fig. 2.
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normal, overweight, obese) as the univariate exposure and adjusting for age and
smoking revealed the categories at baseline to be the only signiﬁcantly predictor of
TKA, 1.867 (1.150, 3.030), p=0.012.5. Discussion
This longitudinal, population based study of women aged between
45 and 65 years of age at baseline demonstrated that both baseline
and year 5 BMI were signiﬁcantly associated with an elevated risk of
TKA over the follow-up period. When adjusted for baseline age and
smoking, the results showed a single unit increase in BMI at baseline
was associated with a 10.0% rise in the risk of TKA by year 19. Change
in BMI between these time points was a less useful predictor of TKA.
These results are consistent with several other large studies that
have demonstrated the positive relationship between obesity and risk
of radiographic knee OA. Spector et al. [12] initially used radiographic
data from a small subgroup (n=58) of this same population cohort
and demonstrated that BMI had a strong effect on the risk of incidence
and progression of radiographic OA. Again using this same population,
Hart et al. [13] examined paired knee radiographs with a 4 year
follow-up between imaging and found those individuals in the upper
BMI tertile had an odds ratio of 2.38 for developing radiographic knee
OA. These results have been further strengthened by several larger
population-based cohort studies that demonstrate the positive
relationship between BMI and incidence of radiographic knee OA
[7,9,15]. Lohmander et al. [11] recently demonstrated the strong
relationship between BMI and knee OA in a study similar to the
present investigation using TKA as an outcome measure for severe
disease.
This study demonstrates that BMI in middle age is the strongest
predictor of the need for TKA with diminishing risks associated with
BMI assessed at later time points. Change in BMI between various time
points however, showed no signiﬁcant association with the risk of
TKA at year 19. The majority of previous studies have only examined
BMI at one time point as an explanatory variable [5,10,16] and thus to
our knowledge the present study, by comparing longitudinal changes
in BMI to future OA outcome data, is unique. The results suggest that
interventions targeting weight loss may have to be targeted prior to
middle age, if the risk of severe knee OA and TKA is to be minimised.
This study has several strengths and potential limitations. This is a
unique, long-term population based study with multiple measures of
BMI and TJA in the same population. TJA is a surrogate measure ofFig. 2. Odds ratios (95% CI) for case control respondents calculated using logistic
regression with TKA (outcome) and BMI (exposure), adjusted for baseline age and
smoking.severe OA in the knee and hip, however it is a surgical end-point with
good clinical relevance to both patient and practitioner. It should be
noted that the UK has a taxpayer-funded public health system, and
thus all individuals in the present study have more-or-less equal
access to TJA with no personal expense. Despite the relative equity in
TJA access, there are some disadvantages of using this as a severe OA
measurement. Hawker et al. [17] have shown that patient willingness
to consider TJA is the primary determinant in the time taken to the
receipt of a ﬁrst TJA. Willingness is in turn affected by level of patient
education, meaning that individual's use of a tax payer-funded TJA
service is probably still inﬂuenced by socioeconomic status.
Other limitations of the data include loss to follow up, the single
sex of the cohort, the mono-ethnicity and the subjectively reported
weight at age 20. Whilst there does not appear to be a systemic
misreporting of data, we acknowledge that this measurement may be
under reported.
In conclusion, we found an increasing risk of TKA due to severe OA
with BMI at baseline and at year 5. Our data suggest that weight loss
interventions for the prevention of severe knee OA may have to be
targeted in early middle age for optimal effect.
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